Captor Therapeutics

Booth 3453
Wroclaw, Poland
Captor Therapeutics is a Swiss-Polish drug discovery company listed on the Warsaw Stock Exchange. It is developing novel drugs in oncology and inflammation using Targeted Protein Degradation.

The most advanced drug is in IND-enabling studies and an authorisation for clinical trials is expected to be filed in 2023. The company entered into a collaboration with Ono Pharmaceutical at the end of 2022 in neurodegeneration and is interested in establishing additional partnerships around our pipeline and our targeted protein degradation discovery platform.
Focus Areas